Ferronova is a cancer diagnostics company, developing surgical oncology tracer systems for improving the staging of complex cancers.
More than 40% of people will be diagnosed with cancer during their lifetime. Successful cancer treatment relies on accurate staging of how far, and where cancer has spread from a primary tumour. Studies in colorectal cancer show up to 27% of patients with early stage disease have micro-metastasis in lymph nodes that are currently undetected.
Ferronova’s injectable magnetic and fluorescent tracers are able to less invasively, more quickly, and more accurately map the spread of cancer to lymph nodes expected to result in: